CAR_Public/030716.mbx            C L A S S   A C T I O N   R E P O R T E R
  
           Wednesday, July 16, 2003, Vol. 5, No. 139

                        Headlines                            

BARR LABORATORIES: Recalls Nortrel 7/7/7 Due To Packaging Errors
CALIFORNIA: Gov. Davis' Supporters File Suit V. Recall Campaign
CANADA: Families of Disabled Veterans Await Ruling on Benefits
CARNEGIE INTERNATIONAL: Agrees To Settle Securities Complaint
CHABOT INVESTMENTS: NY Court Enters Judgement V. Stock Trader

CORDIS CORPORATION: Issues Warning on Risks of Cypher Stent Use
ILLINOIS: Chicago Water District Faces Sexual Harassment Charges
INDIAN FUNDS: House Representatives Junk Effort To Resolve Suit
JOHN HERZOG: RI Court Freezes Assets of Fraudulent Stock Trader
NEW JERSEY: Commuter Train Derails West of New York, 10 Injured

OXYCONTIN LITIGATION: Appeals Court Upholds Suit Certification
PEREGRINE SYSTEMS: SEC Commences Complaint For Financial Fraud
PINNACLE FOODS: Recalls Sandwiches Due To Undeclared Egg Whites
ROBOTIC VISION: MA Court Approves Securities Lawsuit Settlement
SECURITIES LITIGATION: Lawyers Told To Focus on Several Lawsuits

SELECT COMFORT: Recalls 90T Sleep Number Beds For Shock Hazard
TOBACCO LITIGATION: Smoker Launches First Suit V. German Company
TOBACCO LITIGATION: New "Light Cigarettes" Suit Launched in MN
TOBACCO LITIGATION: NV Court Refuses to Certify Smokers' Lawsuit
TOSHIBA AMERICA: Recalls 3,400 Rear Televisions For Shock Hazard

WORLDCOM INC.: SEC Submits Revisions To Civil Penalty Settlement
X-CEL FEEDS: Signs Consent Decree For Food & Drug Act Violation

                Meetings, Conferences & Seminars

* Scheduled Events for Class Action Professionals
* Online Teleconferences


                    New Securities Fraud Cases

CRYO-CELL INTERNATIONAL: Rabin Murray Lodges Stock Lawsuit in FL
DAISYTEK INTERNATIONAL: Bernstein Liebhard Lodges TX Stock Suit
SINGING MACHINE: Vianale & Vianale Lodges Securities Suit in FL

                        *********


BARR LABORATORIES: Recalls Nortrel 7/7/7 Due To Packaging Errors
----------------------------------------------------------------
Barr Laboratories is voluntarily recalling three lots of its
Nortrel 7/7/7 - 28 day (norethindrone and ethinyl estradiol
tablets, USP) oral contraceptive due to packaging errors that
could lead to an increased pregnancy risk.

The recall is effective immediately and involves Lot Numbers
290122001, 290122002, and 290122003 only.  Nortrel 7/7/7 - 28
day is packaged in a blister card containing four horizontal
rows of seven tablets each, with each row representing one week
of tablets.  The first (i.e. top) row should contain yellow
tablets.  The second row should contain blue tablets.  The third
row should contain peach tablets.  The fourth (i.e. bottom) row
should contain white tablets.  The colored tablets contain the
active hormonal ingredients.  The white tablets are placebos
that contain no active ingredient.

Any woman who has received a Nortrel 7/7/7 - 28 day blister card
with tablets in the wrong color sequence could be at an
increased risk of pregnancy.  In addition, changes to the
menstrual cycle, including delayed bleeding, irregular bleeding
or spotting, may occur.  Women taking Nortrel 7/7/7 - 28 day
should carefully check their blister cards and take the
following steps:

     (1) If their blister card contains out-of-sequence tablets,
         they should continue taking the product, immediately
         consult with their health care practitioner for further
         instructions, and return the product to their
         pharmacist for a replacement blister card.  The company
         will replace any out-of-sequence blister card at no
         additional cost and will also cover the cost of a
         pregnancy test for any woman who purchased and used a
         blister card with out-of-sequence tablets;

     (2) If their blister card contains the correct sequence of
         tablets, they should continue taking the product.

Women who are not certain whether their blister card contains
the correct sequence of tablets should contact the company or
their pharmacist immediately, but should continue taking the
product until otherwise instructed by their health care
practitioner or pharmacist.

Women who believe they may have previously taken Nortrel 7/7/7 -
28 day from an out-of-sequence blister card and who are
concerned about pregnancy or irregular bleeding should consult
their health care practitioner for further instructions.

The Company said that out of approximately 470,000 packages of
marketed Nortrel 7/7/7 - 28 day that are subject to the recall,
it has received two reports in which the tablets in the blister
are reversed, causing the white placebo row to be in the first
row labeled "start" (i.e., week one) rather than in the last row
labeled "Week 4."  Additionally, the lot number and expiration
date were not visible on the back of these two cards.

Nortrel, an oral contraceptive that is a generic form of Ortho-
Novum 7/7/7, is sold in pharmacies.  The recalled lots were
distributed between January and April 2003.

For more details, contact Barr Laboratories, Inc. Drug
Information Line by Phone: 1-800-222-0910 extension 33302.


CALIFORNIA: Gov. Davis' Supporters File Suit V. Recall Campaign
---------------------------------------------------------------
Allies of California's Democratic Governor Gray Davis intend to
file a class action in the Los Angeles Superior Court relating
to the signature gathering process that could possibly make Gov.
Davis the first California governor to face a recall election,
NBC11.com reports.  The group named Rescue California Recall
Gray Davis announced early this week that they were turning in
more than 1.6 million signatures to counties to get the recall
process in motion.

Gov. Davis' allies, the Lawyers for Taxpayers Against the
Governor's Recall, stated that there were widespread
illegalities in the Republican-led signature drive, including
the use of signature gatherers who were not registered to vote
in California.  The signature gatherers allegedly paid $1 per
signature and collected signatures without witnessing the
signing, as required.  They asserted that two signature
circulators already admitted in signed affidavits to being
convicted felons, they said.

"The real question is whether or not, under the requirements of
the laws of California, there are sufficient numbers of valid
signatures to sustain this recall, or whether or not the process
has been poisoned to the point that they can't reach the number
they reached," attorney Paul Kiesel told a conference call with
reporters, NBC11.com reports.

The suit will be filed against Secretary of State Kevin Shelley,
a Democrat, and the county clerks in Los Angeles, Orange and San
Diego counties, which yielded more signatures than any others.  
The suit will also name several individual state residents as
plaintiffs and will seek class-action status on behalf of
California voters and taxpayers.  

Rescue California Recall Gray Davis' officials labeled the suit
"frivolous" and predicted it would be dismissed in court.  "Gray
Davis can't explain or defend his dismal record as governor, so
he has resorted to a cynical, frivolous lawsuit to try to thwart
the will of the people," Dave Gilliard, Rescue California's
director told NBC11.com.  "We had over 150,000 circulators of
our petition and every circulator was a registered voter in
California, which is what the law requires, and we are very
confident that there's no problem with them."

Gov. Davis' supporters concede that a recall election now looks
inevitable.  However, a legal tussle could delay it until March,
when heavy Democratic turnout for the state's presidential
primary could help Gov. Davis.  A group of recall proponents
earlier sued Mr. Shelley and four counties Thursday to try to
get the signature counting to move faster; no action has been
taken on that lawsuit.


CANADA: Families of Disabled Veterans Await Ruling on Benefits
--------------------------------------------------------------
The families of thousands of seriously disabled veterans would
be deprived of monies owed to them by the Federal Government if
the Supreme Court agrees with a ruling of the Ontario Superior
Court, made three years ago.

"It is our understanding that the Supreme Court of Canada is
dealing only with the matter of whether the Lower Court was
correct in basing its far-reaching decision on the former
Charter of Rights, which came into force on April 17, 1982,"
said Cliff Chadderton, Chairman of the National Council of
Veteran Associations.  "Lawyers advising The War Amputations of
Canada have stated that the Charter of Rights and Freedoms
supercedes the old Charter and generally gives the Supreme Court
Judges the right only to interpret the law -- not to make new
law."

The information which appears to be coming from the Public
Relations Firm, acting for the lawyers in Windsor, Ontario, who
have been promoting this class action, appears to give the
impression that the issue would deprive the families of many
seriously disabled veterans in regard to the Federal Government
policy which was not to pay interest on accounts administered on
behalf of veterans who were in institutions and unable to look
after their own finances.
    
Mr. Chadderton stated that admittedly it was a complex situation
but that it was entirely wrong to indicate that the Federal
Government was withholding monies from families of seriously
disabled veterans.  He stated that most of the combat veterans
who came back from wars of the 20th Century were not generally
affected.  On the other hand, the majority of veterans who were
in long-term care facilities are now dead and this looks very
much like what he called a "cash grab at the Federal Treasury."  

He went on to say that most of the beneficiaries would be
distant relatives, basing his view on the fact that the case
goes back to 1917 and the majority of the veterans who were in
DVA institutions are now dead.  "This is an issue which
generally affects distant relatives - not the veterans who
fought in our wars," he said.

Mr. Chadderton continued that if genuine veterans were being
deprived of benefits, his organization would be one of the
first to challenge the Federal Government.  "On the other hand,"
he said, "it was never the intention of the Veterans Pension Act
to provide assistance to what even the law firm behind the
class-action has described as '52nd degree cousins'."


CARNEGIE INTERNATIONAL: Agrees To Settle Securities Complaint
-------------------------------------------------------------
The United States Securities and Exchange Commission filed a
civil injunctive action in the United States District Court for
the District of Columbia against Carnegie International
Corporation, a company headquartered in Laurel, Maryland, and
six individual defendants.  The individual defendants are:

     (1) E. David Gable, Carnegie's chairman,

     (2) Lowell Farkas, Carnegie's president and chief executive
         officer,

     (3) David Pearl, a lawyer and the former corporate
         secretary of Carnegie,

     (4) Richard J. Greene, Carnegie's former chief financial
         officer,

     (5) Scott Caruthers, a former Carnegie director, and

     (6) Dashielle Lashra Caruthers, the wife of Scott
         Caruthers

The Caruthers are also named as relief defendants.  All the
defendants except Mr. Gable have consented to the entry of final
judgments in settlement of this matter.
     
The complaint alleges, among other things, that Mr. Gable, Mr.
Farkas, and Mr. Pearl carried out a financial fraud at Carnegie
that resulted in Carnegie improperly reporting revenue and
income on three transactions in filings with the Commission.   
The transactions related to Carnegie's sale of a former
subsidiary, Electronic Card Acceptance Corporation, and certain
business assets of a second subsidiary, Talidan Limited, and its
granting of distribution rights to a telephone voice-recognition
product called MAVIS.  

The filings at issue are the company's original and amended
registration statements, filed in October 1998 and February
1999, respectively, and its original and amended 1998 Form 10-
KSB annual report, filed in April 1999 and January 2000,
respectively.
     
The complaint further alleges that Carnegie senior management
arranged for the sale of Carnegie shares through management-
controlled entities, and had proceeds from these sales
transferred to Carnegie as purported payment on certain of these
transactions.  

According to the complaint, Carnegie's accounting for these
transactions, and the company's failure to make required
disclosures concerning these transactions, including the
involvement of related parties, was not in accordance with
generally accepted accounting principles (GAAP).  The complaint
further alleges that Carnegie's financial reporting was highly
susceptible to the financial fraud because Mr. Greene,
Carnegie's former chief financial officer, failed to implement
an adequate system of internal accounting controls.
     
Carnegie is also alleged to have materially misrepresented
Talidan's expected future performance in the company's 1998 Form
10-KSB by failing to disclose known adverse events and
uncertainties that were materially impacting Talidan's revenues.  
Finally, the company is alleged to have materially
misrepresented the terms of other purported MAVIS distribution
agreements in press releases issued in 1998.

According to the complaint, Mr. Gable and Mr. Pearl, along with
the Caruthers, personally benefited from this fraud by selling
Carnegie shares at inflated prices through an offshore trust,
and they failed to make required disclosures concerning their
beneficial ownership and sales of Carnegie shares.
     
Carnegie was charged with securities fraud in violation of
Section 17(a) of the Securities Act of 1933, Section 10(b) of
the Securities Exchange Act of 1934, and Exchange Act Rule 10b-
5, and with violating the reporting, books-and-records, and
internal controls provisions of Exchange Act Sections 12(g),
13(a), 13(b)(2)(A), and 13(b)(2)(B), and Exchange Act Rules 12b-
20 and 13a-1.
     
Mr. Gable, Mr. Farkas, and Mr. Pearl were each charged with
securities fraud in violation of Exchange Act Section 10(b) and
Exchange Act Rule 10b-5; falsifying Carnegie's books, records,
and accounts, and circumventing or failing to implement internal
accounting controls, in violation of Exchange Act Section
13(b)(5) and Exchange Act Rule 13b2-1; misleading Carnegie's
auditors in violation of Exchange Act Rule 13b2-2; and aiding
and abetting Carnegie's violations of Exchange Act Sections
12(g), 13(a), 13(b)(2)(A), and 13(b)(2)(B), and Exchange Act
Rules 12b-20 and 13a-1.  Mr. Gable and Mr. Pearl were also
charged with violating the antifraud provisions of Securities
Act Section 17(a) and the stock ownership disclosure
requirements of Exchange Act Section 16(a) and Exchange Act
Rules 16a-2 and 16a-3.
     
Mr. Greene was charged with failing to implement internal
accounting controls in violation of Exchange Act Section
13(b)(5), and with aiding and abetting Carnegie's violation of
Exchange Act Section 13(b)(2)(B).

The Caruthers were each charged with violating the stock
ownership disclosure provisions of Exchange Act Sections 13(d)
and 16(a) and Exchange Act Rules 13d-1, 13d-2, 16a-2, and 16a-3,
and, in their capacity as relief defendants, with receiving
unjust enrichment as a result of the fraud perpetrated by the
other defendants.
       
Without admitting or denying the allegations in the Commission's
complaint, all of the defendants except Mr. Gable have agreed to
settle the Commission's charges by consenting to the entry of
final judgments that, if approved by the Court, would
permanently enjoin them from further violations of the
securities laws.  In addition, Mr. Farkas and Mr. Pearl have
consented to be permanently barred from serving as officers or
directors of any public company.  The Court judgments would not
impose civil penalties or disgorgement obligations on the
settling individual defendants and relief defendants based on
the sworn representations each of them made to the Commission
regarding his or her financial condition.

With regard to Mr. Gable, the Commission's complaint seeks the
entry of a final judgment permanently enjoining him from future
violations of the federal securities laws, permanently barring
him from serving as an officer or director of a public company,
and ordering him to pay disgorgement (with prejudgment interest)
and civil penalties.
     

CHABOT INVESTMENTS: NY Court Enters Judgement V. Stock Trader
-------------------------------------------------------------
Judge Naomi R. Buchwald of the United States District Court for
the Southern District of New York, entered a judgment against
Peter W. Chabot and Chabot Investments, Inc. for violating the
anti-fraud provisions of the federal securities laws.  

The United States Securities and Exchange Commission filed the
suit, which alleged that, beginning in 1999, Mr. Chabot,
individually and through his entities, raised over $1.2 million
from 14 investors by making material misrepresentations and
omissions to them concerning an alleged hedge fund.  Mr. Chabot
falsely claimed he was an experienced trader and that he had
developed a mathematical model to predict when to buy stocks and
whether to take long or short positions.  Mr. Chabot also
prepared false and misleading account statements for the
investors, claiming large returns on the purported investments
made by the alleged hedge fund.
          
As alleged in the complaint, Mr. Chabot did not buy stocks or
other securities with the investors' funds.  Instead, he used
their money for his personal expenses.  On January 8, 2002, Mr.
Chabot pled guilty to one count of securities fraud and one
count of wire fraud before the court.  On February 27, 2002, Mr.
Chabot was sentenced to 27 months imprisonment, supervised
release of 36 months, and ordered to pay restitution of
$1,265,868.
     
Mr. Chabot and Chabot Investments, Inc., without admitting or
denying any of the allegations of the complaint, consented to
entry of the final judgment, which permanently enjoined them
from violations of Section 10(b) of the Securities Exchange Act
of 1934 and Rule 10b-5 thereunder, Section 17(a) of the
Securities Act of 1933, and Sections 206(1) and (2) of the
Investment Advisers Act of 1940.   The final judgment also
provided that any remaining assets and funds in Chabot
Investment Inc.'s bank accounts be applied in partial
satisfaction of the February 27, 2002 order in the criminal
action, which ordered Mr. Chabot to pay restitution to his
victims.  

In addition, on June 27, 2003, the court entered a Notice of
Voluntary Dismissal against defendants, The Synergy Fund LLC,
Sirens Investments, Inc., and Sirens Synergy.  The Commission
moved to dismiss its claims against these defendants because,
although referenced in documents prepared by Mr. Chabot, they
were later determined not to exist.  

On July 3, based on the entry of the final judgment against Mr.
Chabot, the Commission also instituted settled administrative
proceedings against him pursuant to Section 203(f) of the
Investment Advisers Act of 1940.  Without admitting or denying
the Commission's findings, Mr. Chabot consented to the entry of
the Commission's Order, which permanently bars him from
associating with any investment adviser.  
     

CORDIS CORPORATION: Issues Warning on Risks of Cypher Stent Use
---------------------------------------------------------------
Cordis Corporation (Cordis) issued a warning to health care
professionals to inform them of the rare but potential risk of
thrombosis associated with the use of its product the CYPHER
Sirolimus-Eluting Coronary Stent (CYPHER stent).  This letter
also provides clarification on the safe use of the product in
accordance with the scientific evidence that led to product
approval.

The CYPHER stent was approved in April 2003 for patients
undergoing angioplasty procedures to open clogged coronary
arteries.  Since the product's introduction it is estimated that
over 50,000 patients have received a CYPHER stent.  To date, FDA
has received 47 Medical Device Reports (MDRs) of stent
thrombosis occurring at the time of implantation or within a few
days of implantation.

The Food and Drug Administration (FDA) is carefully reviewing
the reports of adverse events and is working closely with the
company to determine the exact causes and reduce the incidence
of thrombosis.  From the reports received so far, it is unclear
what effect the CYPHER stent has on thrombosis risk and what
factors may contribute to the risk.  As part of the approval for
this product, FDA required Cordis to undertake post-approval
studies which will help FDA track adverse events more
accurately, as well as help determine whether the thrombosis
rate in current clinical experience differs from the rate seen
in pre-approval studies.

Until more is known about the situation, FDA fully supports
Cordis' recommendations to health care professionals which may
help reduce the incidence of adverse events.  These include:

     (1) selection of the appropriate stent size:  the stent
         size should match the diameter of the vessel as closely
         as possible;

     (2) selection of appropriate patients for implantation:  
         the stent is indicated for improving coronary luminal
         diameter in previously untreated vessels and is not
         indicated for the treatment of restenosis (reclogging
         of a previously stented vessel);

     (3) use of an adequate anti-plalelet regimen:  doctors are
         reminded to give adequate doses of medication that
         reduce the risk of clot formation;

     (4) use of the proper technique for stent deployment: the
         stent should be fully deployed and in contact with the
         vessel wall.  Poor stent deployment is a factor that
         can increase the thrombosis risk.

In addition, all health care professionals are reminded and
encouraged to report their experiences to FDA's Medical Device
Reporting (MDR) System through MedWatch by Phone: 1-800-FDA-1088
or visit the Website: http://www.fda.gov/MedWatch


ILLINOIS: Chicago Water District Faces Sexual Harassment Charges
----------------------------------------------------------------
Chicago's Water Reclamation District has an environment where
sexual behavior and harassment are pervasive, an eight-month
investigation revealed, the Red Streak reports.  

Between 1992 and 2003, the district already received 11
complaints of sexual harassment, but Callie Baird, an attorney
who conducted more than 60 interviews and reviewed 1,000 pages
of documentation, told the Red Streak the numbers don't tell the
story.

The work environment for 2,200 employees is a "Dial- or
Mitsubishi-type class action lawsuit waiting to happen," Ms.
Baird said.  Sexual behavior, suggestion and acts are pervasive,
the report alleged.  Allegations included female workers being
harassed, touched in the genital area and breasts, followed from
work, shown pictures depicting oral sex and being asked for sex.


INDIAN FUNDS: House Representatives Junk Effort To Resolve Suit
---------------------------------------------------------------
Two representatives agreed to abandon an attempt to end the
lawsuit filed against the United States Department of Interior
on behalf of hundreds of American Indians, over royalties the
government owes them for the use of their lands, the Associated
Press reports.

House Resources Committee Chairman Richard Pombo, R-Calif.
Agreed with Rep. Charles Taylor, R-N.C., chairman of the House
Appropriations subcommittee on the Interior, to remove the
proposal which would have given Interior Secretary Gale Norton
sweeping authority to settle the seven-year-old suit, which
charges the department with mismanaging oil, gas, timber,
grazing and other royalties from Indian lands.  Rep. Pombo and
Indian leaders objected strongly to the provision at a hearing
last week.

Earlier, lead plaintiff Elouise Cobell assessed the amount that
the government owed them to be about $176 billion.  The
government balked at this amount, saying the amount could
probably be no more than a few million dollars.  Under the
provision, Sec. Norton would have the discretion to do an
accounting as she saw fit, without direction from the court.  
The provision would also have forced each Indian landowner to
challenge the accounting results individually instead of through
a class action.

Ms. Cobell denounced the provision, which was crafted without
consulting Indian tribes, telling AP it was "designed to
eviscerate the rights of Indian beneficiaries and steal from us
the victories we have achieved through seven years of
litigation."

Rep. Pombo also objected to the measure because Indians were not
consulted and his committee was not included in drafting it, but
he still believes the lawsuit should be resolved.  "This
situation is having an increasingly negative impact on the
availability of resources for the critical needs such as roads,
schools and health care facilities in Indian country," Rep.
Pombo told AP.

Ms. Cobell said in a statement that the stripping of the
offensive provision from the bill will allow the litigation to
continue "and set a framework for what we hope can be an fair
and equitable resolution of our seven-year legal fight."


JOHN HERZOG: RI Court Freezes Assets of Fraudulent Stock Trader
---------------------------------------------------------------
The United States District Court in Rhode Island entered a
default judgment against Johan Hertzog, a defendant in an action
filed by the United States Securities and Exchange Commission in
April 2002.  

The Commission alleged in its complaint that Mr. Hertzog and
others participated in a fraudulent offering scheme that raised
at least $52 million from investors.  In the default judgment,
the Honorable Mary M. Lisi permanently enjoined Mr. Hertzog  
from future violations of the antifraud  provisions of the
federal securities laws and ordered him to pay approximately $25
million in disgorgement, interest and a penalty.
     
The Commission filed its action against Mr. Hertzog and eight
other defendants and a relief defendant on April 1, 2002,
alleging that Mr. Hertzog played a key role in a scheme that
made fraudulent representations to investors through a high
yield trading program.

According to the Commission's complaint, the scheme, which
raised approximately $52.75 million from six investors, was
perpetrated by Mr. Hertzog and others through entities formerly
known as Brite Business S.A. and Brite Business Corporation.  
The complaint alleges that agreements Brite Business entered
into with investors promised astronomical returns (such as a
nearly 300% return in twelve banking days) and possessed
characterizations of investment programs typical of "prime bank"
investment schemes to defraud.   

According to the Commission's complaint, during his contacts and
correspondence with investors, Mr. Hertzog held himself out to
be director, chairman and CEO of Brite Business.  The complaint
further alleges that, between 1999 and 2001, Mr. Hertzog and
others associated with Brite Business misappropriated,
transferred or lost approximately $20 million in investor funds.
     
On April 3, 2002, the court issued a temporary restraining order
freezing the assets of Mr. Hertzog and others.  The June 20,
2003 final judgment enjoins Mr. Hertzog from future violations
of Section 17(a) of the Securities Act of 1933 and Section 10(b)
of the Securities Exchange Act of 1934 and Rule 10b-5
thereunder, orders him to pay disgorgement in the amount of
$19,800,000, plus prejudgment interest in the amount of
$4,863,372.72, for a total amount of $24,663,372.72, and
assesses a $100,000 civil monetary penalty against him.
     

NEW JERSEY: Commuter Train Derails West of New York, 10 Injured
---------------------------------------------------------------
A New Jersey Transit commuter train derailed in a remote area
near Secaucus, about five miles west of New York shortly before
8 a.m on Monday July 14, 2003, injuring ten people, the
Associated Press reports.  Two train cars jumped the tracks and
halted rail traffic at the height of the morning rush on a busy
line between Newark and New York.  

Tim Donnelly, a passenger, said the 12-car train had just
crossed a bridge over a small waterway when there was a scraping
sound and the train "made a hard stop."  "There was a little bit
of panic right when the cars derailed," he told AP.

The injured were taken to hospitals, but officials say none of
their injuries was life-threatening.  About 1,200 passengers
were transferred to another train two hours after the derailment
to complete their trip into New York.

New Jersey Transit and Amtrak trains were delayed, because only
one track remained open to handle both north and southbound
traffic, Amtrak spokeswoman Karina VanVeen told AP.  The cause
of the accident has not yet been determined, NJ Transit said.


OXYCONTIN LITIGATION: Appeals Court Upholds Suit Certification
--------------------------------------------------------------
The Ohio Twelfth Circuit Court of Appeals issued a landmark
ruling when it affirmed certification of a class action
consisting of thousands of Ohio residents injured by the
narcotic OxyContinr.

By affirming the decision of Butler County Trial Judge Michael
Sage, the Court of Appeals held that thousands of injured Ohio
residents may go to trial and prove that defendants Purdue
Pharma and Abbott Laboratories (NYSE: ABT) sold and distributed
OxyContinr and encouraged the medical community to widely
prescribe OxyContinr despite knowing that OxyContinr was highly
addictive and unsuited for most patients.  The Twelfth Circuit's
decision is believed to be the first appellate court decision
that has affirmed a statewide class action on behalf of all
OxyContinr patients.  

Counsel for the class, Stanley M. Chesley of Cincinnati, Ohio,
and Scott Frederick of Hamilton, Ohio, praised the Appellate
Court for its decision.  According to Mr. Chesley, "The Court of
Appeals clearly found that the plaintiffs have provided evidence
that OxyContinr has ruined lives.  Class certification is the
only way these victims will be able to fight the Defendants and
protect their rights."

Mr. Chesley further emphasized that their goal is not to
eliminate the sale and use of OxyContinr.  "The purpose of this
class action is to hold Purdue and Abbot liable for their
unconscionable sale and promotion of OxyContinr as a pain
panacea.  Purdue and Abbot knew that OxyContinr was the
equivalent of morphine and yet it marketed OxyContinr as if it
were little more than a simple pain medication instead of a
dangerous narcotic, even more dangerous than heroin."

OxyContinr is more than twice as potent as Purdue Pharma's
morphine-based MS Continr.  Yet, Purdue Pharma and Abbott sold
and marketed the drug by hiding the similarities between
morphine and OxyContinr.  Mr. Chesley asserted that this
deception resulted in thousands of Ohio residents becoming
addicted and forced to undergo painful withdrawal.  In many
cases, Mr. Chesley said the addiction led to the breakup of Ohio
families, the loss of jobs and a disruption of life that was far
worse than the pain that OxyContinr was intended to relieve.

For more details, contact Stanley Chesley by Phone:
(513) 300-7700 or contact Scott Frederick by Phone:
(513) 737-5100


PEREGRINE SYSTEMS: SEC Commences Complaint For Financial Fraud
--------------------------------------------------------------
The United States Securities and Exchange Commission (SEC) sued
San Diego-based software company Peregrine Systems, Inc., in the
United States District Court for the Southern District of
California, for a massive financial fraud at the company that
spanned 11 fiscal quarters.  Simultaneously with the filing of
the complaint, the commission submitted to the court, for its
approval, a partial settlement with the Company.

According to the Commission's complaint, the purpose of the
fraudulent scheme was to inflate the Company's revenue and stock
price.  To achieve that end, the Company filed materially
incorrect financial statements with the Commission concerning
the quarter ended June 30, 1999, through the quarter ended
December 31, 2001.  

In 2003, the Company restated its financial results for those
quarters.   In its restatement, the Company reduced previously
reported revenue of $1.34 billion by $509 million, of which at
least $259 million was reversed because the underlying
transactions lacked substance.
          
The complaint alleges that the Company improperly booked
millions of dollars of revenue for purported software license
sales to resellers.  These transactions were non-binding sales
of Peregrine software with the understanding-reflected in secret
side agreements-that the resellers were not obligated to pay
Peregrine.  Those involved in the scheme called this "parking"
the transaction.  Peregrine personnel parked transactions when
Peregrine was unable to complete direct sales it was negotiating
(or hoping to negotiate) with end-users, but needed revenue to
achieve its forecasts.  

Peregrine engaged in other deceptive practices to inflate the
company's revenue, including entering into reciprocal
transactions in which Peregrine essentially paid for its
customers' purchases of Peregrine software.  Peregrine routinely
kept its books open after fiscal quarters ended, and improperly
recorded as revenue, for the prior quarter, software
transactions that were not consummated until after quarter end.   
Certain Peregrine officers characterized these transactions as
having been completed on  "the 37th of December."  Peregrine
senior officers, and sales and finance personnel knew, or were
reckless in not knowing, that the applicable accounting rules
prohibited revenue recognition on these and other transactions
for which Peregrine booked revenue.

The complaint alleges that, by various means, certain Peregrine
officers and employees fraudulently concealed the revenue
inflation scheme.  When Peregrine booked revenue for the non-
binding reseller contracts, and the customers predictably did   
not pay, receivables- some of them bogus-ballooned on
Peregrine's balance sheet.  Large aged accounts receivable were
not being paid, an indication that Peregrine's financial health
was deteriorating.  To make it appear to investors that
Peregrine was collecting its receivables more quickly than it
was, a senior officer entered into financing arrangements with
banks to exchange receivables for cash.  Peregrine improperly
accounted for these financing arrangements as sales of the
receivables and removed them from the company's balance sheet.  

There were several problems with this.  First, because Peregrine
had given the banks recourse, and frequently paid or repurchased
unpaid receivables from them, Peregrine should have accounted
for the financing arrangements as loans and left the receivables
on its balance sheet.   Second, some of the "sold" receivables
were not valid because the customers were not obligated to pay
Peregrine.  Third, several of the "sold" invoices were fake.   
For example, in June 2001, Peregrine's senior treasury manager,
with senior management's approval and encouragement, created a
false $19.59 million invoice and sold it to a bank.  As a
result, Peregrine's financial statements and books and records
overstated Peregrine's cash flow from operations, and
understated its accounts receivable.

The complaint also alleges that, as part of the cover-up,
Peregrine personnel wrote off millions of dollars in
uncollectible- primarily sham -receivables, to acquisition-
related accounts in Peregrine's financial statements and books
and records.  These write-offs were improper because they had
nothing to do with acquisitions, and because the Peregrine
personnel who directed the write-offs knew, or were reckless in
not knowing, that certain written-off receivables should not
have been recorded as revenue in the first place.   

Peregrine misled investors by not including the write-offs in
its pro-forma operating results, and by making the write-offs
appear on Peregrine's income statement as one-time charges
rather than expenses from operations.  Through its officers and
employees, Peregrine knew that:

     (1) a substantial portion of these receivables should not
         have been recorded as revenue in the first place;

     (2) the receivables were not impaired by acquisitions;  
         and

     (3) it was inappropriate to make it appear to the investing
         public that the write-offs related to non-recurring
         events.

The Commission's complaint seeks to permanently enjoin Peregrine
from violating certain antifraud provisions of the federal
securities laws (Section 17(a) of the Securities Act of 1933,
Section 10(b) of the Securities Exchange Act of 1934 (Exchange
Act) and Exchange Act Rule 10b-5), and from violating certain
reporting, books and records, and internal controls provisions
(Exchange Act Sections 13(a), 13(b)(2)(A) and 13(b)(2)(B), and
Exchange Act Rules 12b-20, 13a-1, and 13a-13).  The complaint
also seeks disgorgement of ill-gotten gains, prejudgment
interest, and civil monetary penalties.
          
Peregrine, without admitting or denying the allegations of the
Commission's complaint, has agreed:

     (i) to be enjoined from violating the antifraud, reporting,
         books and records, and internal controls provisions of
         the federal securities laws;

    (ii) to disclose the current condition of its internal
         controls and financial reporting procedure, when a
         reorganization plan under Chapter 11 of the Bankruptcy
         Code becomes effective;

   (iii) to comply, on an accelerated basis, with the rules
         regarding management's report on internal controls,  
         implementing Section 404 of the Sarbanes-Oxley Act of
         2002;

    (iv) to retain an Internal Auditor to ensure that
         Peregrine's financial results are accurately reported
         in Peregrine's public financial statements;

     (v) to appoint a Corporate Compliance Officer to perform an
         ongoing review of Peregrine's corporate governance
         policies and practices; and  

    (vi) to commence a training and education program for its  
         officers and employees, to prevent violations of the
         federal securities laws.   

The partial settlement provides that the amount of disgorgement
and/or civil penalty to be paid by Peregrine, if any, shall be
determined at a later date.  In determining to accept
Peregrine's offer of partial settlement, the Commission
considered remedial acts promptly undertaken by Peregrine and
cooperation afforded the Commission staff.


PINNACLE FOODS: Recalls Sandwiches Due To Undeclared Egg Whites
---------------------------------------------------------------
Pinnacle Foods Corporation of Mountain Lakes, NJ recalled
"Hearty Hero Meatball Sandwiches" mispacked in "Hearty Hero
Cheeseburger Sandwich" Cartons.  The meatballs contain egg white
protein that is not listed on the Cheeseburger Sandwich Carton.  
People who have an allergy or severe sensitivity to egg white
protein may run the risk of a serious or life-threatening
allergic reaction if they consume this product.

The "Hearty Hero Meatball Sandwiches" may have been distributed
regionally through retail stores located only in the States of
Pennsylvania, Delaware, Maryland, Virginia and West Virginia.  
No illnesses have been reported to date.  The recall was
initiated after it was discovered that some of the cartons
labeled as "Hearty Hero Cheeseburger Sandwiches" may contain
meatball sandwiches instead of cheeseburger sandwiches.  The UPC
code for the "Hearty Hero Cheeseburger Sandwich" Cartons is:
51000 04350

The following production code would appear on the carton of the
affected product: MAR 2004 122902

For more details, contact the Company by Phone: 1-800-554-5680.


ROBOTIC VISION: MA Court Approves Securities Lawsuit Settlement
---------------------------------------------------------------
The United States District Court, District of Massachusetts
approved the settlement proposed by Robotic Vision Systems, Inc.
(RVSI) (NasdaqSC: ROBV) relating to a securities class action
against it, Pat V. Costa, its Chief Executive Officer, and Frank
Edwards, its former Chief Financial Officer.

The plaintiffs seek damages for alleged false and misleading
statements made prior to the Company's announcement that it
would restate its financial results in fiscal year 2000 and the
first quarter of fiscal year 2001.  The parties to this action
later agreed in principle to settle this matter, subject to the
parties drafting and executing appropriate settlement documents,
conducting certain limited confirmatory discovery and obtaining
court approval.

"We are pleased to put this lawsuit behind us," said Pat V.
Costa, Chairman and CEO of RVSI.  "We have many opportunities
before us that require management's full attention and that can
build shareholder value."

The $5.5 million cost of the settlement will be borne by RVSI's
insurance carrier.


SECURITIES LITIGATION: Lawyers Told To Focus on Several Lawsuits
----------------------------------------------------------------
New York federal judge Shira Scheindlin ordered lawyers on both
sides of the IPO securities class action to decide by early next
year which handful of cases they want to focus on when the case
finally goes to trial, Reuters reports.

Judge Scheindlin set for 2004 the trial for the securities class
action involving 55 investment banks and more than 300
companies.  The suits charge the defendants with artificially
manipulating stock prices by through fraudulent accounting
schemes.  The suits allege that analysts manipulated the market
with optimistic research and banks ramped up commissions in
exchange for access to IPO shares.

Lawyers intend to seek class certification for the suit, before
both sides will proceed with discovery and examine documents
such as telephone records, trading documents, pitch books and
organizational charts.

Judge Scheindlin ruled that lawyers must decide on 10 to 20
cases that they wish to focus on January.  This will allow both
sides to avoid sifting through every detail of the 309 companies
in the suit.  She also ruled that the banks, including Citigroup
and Goldman Sachs Group, must make the documents they handed
over to US government prosecutors who investigated the banks
available to lawyers for the investors by the middle of next
month, Reuters states.

"The objective of everybody is to try and get these cases
understandable," Melvyn Weiss, a partner in plaintiff's firm
Milberg, Weiss, Bershad, Hynes & Lerach LLP and chairman on the
plaintiffs executive committee, told Reuters.


SELECT COMFORT: Recalls 90T Sleep Number Beds For Shock Hazard
--------------------------------------------------------------
Select Comfort Corporation is cooperating with the United States
Consumer Product and Safety Commission by voluntarily recalling
90,000 Sleep Number Beds.  When exposed to severely cold
temperatures and impact, such as may occur during shipping, the
power cord insulation on the electric air pump can crack,
creating a short-circuit or exposing live electrical wires and
presenting a shock or electrocution hazard.

Select Comfort has received two reports of cords cracking.  No
injuries or property damage have been reported.

This program includes all Sleep Numberr Beds by Select Comfort
sold from November 2002 through March 15, 2003 that were shipped
through or to cold weather locations.  These items were directly
sold through Select Comfort as well as certain specialty
mattress retailers and QVC nationwide from November 2002 through
March 15, 2003 for between $500 and $3,300 per bed set.

For more details, contact the Company by Phone: (800) 326-3541
between 7 a.m. to 10 p.m. CT Monday through Friday and 10 a.m.
to 5:30 p.m. CT Saturday and Sunday, or by E-mail:
questions@selectcomfort.com


TOBACCO LITIGATION: Smoker Launches First Suit V. German Company
----------------------------------------------------------------
A 55-year-old German man has filed a suit against German
cigarette manufacturer Reemtsma, alleging the Company's products
caused him to have a heart attack, Deutsche Welle reports.  The
suit is the first ever filed in Germany and evokes the billion
dollar anti-tobacco lawsuits filed in the United States.

A court in the State of North-Rhine Westphalia has agreed to
hear the EUR400,000 (US$451,400) lawsuit filed by Wolfgang
Heine.  Mr. Heine alleges that chain smoking caused his heart
failure, which ultimately led him to undergo two expensive
bypass operations.  He alleges the company failed to inform him
of the dangers of smoking in the 1980s, the newsmagazine Focus
reports.  The first proceedings are expected to begin in
November.

A spokesman at insurance company Barmer told Deutsche Well that
he was "skeptical" about the case "fundamentally changing
anything."  He said medical files in the case would have to
"without a doubt" trace Mr. Heine's illness to his smoking.

The German tobacco industry has been sheltered so far from
lawsuits similar to the ones filed against American companies.  
However, German firms fear that if one suit succeeds in court,
it will open a floodgate for similar lawsuits.  With close to 18
million smokers who spend an estimated EUR21 billion yearly to
support their habit, the stakes would be enormous if a wave of
litigation were to strike.


TOBACCO LITIGATION: New "Light Cigarettes" Suit Launched in MN
--------------------------------------------------------------
Big tobacco firms Philip Morris and R.J. Reynolds face two
lawsuits in Minnesota, alleging them with misleading the public
by advertising light cigarettes as less harmful than other
cigarettes, the Associated Press reports.  

The suits are part of the new kind of lawsuits sweeping the
country at the moment.  Unlike personal injury cases in which
sick smokers sue tobacco companies, these new cases explore
whether the tobacco companies mislead the public by advertising
light cigarettes as less harmful than other cigarettes.  

"They are inducing the purchase of a product based on fraud,"
Gale Pearson, an attorney who is handling both cases told the
Associated Press.

The two suits charge the firms with violating Minnesota consumer
protection laws when they marketed Marlboro Lights and Camel
Lights as having lower tar and nicotine and other brands.  In
March, a similar suit was filed in Illinois against Philip
Morris.  The jury returned a $10.1 billion verdict against the
Company, but the verdict is currently being appealed.

The Company has asked the court to dismiss the suit, saying it
is barred by the statute of limitation and there was no evidence
of injury to possible class members.  Hearing is scheduled for
November 3, to decide whether the case can proceed as a class
action.

Tobacco companies are hurrying to push new laws to limit the
bonds companies must post to appeal a court verdict, because of
this new wave of litigation sweeping the courts.  Nearly 30
states have revised their laws out of fear that bankruptcy would
let the cigarette makers off the hook for the billions of
dollars they owe under various settlements.

Mr. Pearson said her clients were duped into believing that
light cigarettes were less harmful than others.  "They're upset
that they have been lied to and they feel they are owed
something based on the deception," Mr. Pearson told AP.

Philip Morris is the target of about 17 "lights" cases pending
in 14 states.  William Ohlemeyer, vice president and associate
general counsel for Philip Morris, predicted that the company
will prevail, if not at the trial level, then on appeal.  He
told AP the Illinois verdict is an anomaly.


TOBACCO LITIGATION: NV Court Refuses to Certify Smokers' Lawsuit
----------------------------------------------------------------
United States District Court in Las Vegas, Nevada refused to
grant class certification to five class actions filed against
tobacco companies on behalf of smokers seeking damages from
them, the Associated Press reports.  Federal Judge Lloyd D.
George ruled that the request for class certification failed to
meet the standard to proceed as a group.

The court stated that there were "a number of factors identified
by the defendants demonstrating that individual issues . not
only exist as to each member of the class, but will vary
extensively as to each member."

"The court examined the issues and agreed that the law simply
does not permit smoking cases to be tried as class actions,"
William S. Ohlemeyer, Philip Morris USA vice president and
associate general counsel told AP.

The Company said the decision could influence similar suits
nationwide.  A Florida appellate court recently ordered a class
action decertified, saying it failed to meet legal requirements
for class-action treatment.

Martin L. Holton III, a lawyer and vice president for R.J.
Reynolds Tobacco Co., called tobacco class actions simply
inappropriate "because they always involve a wide variety of
individuals whose legal claims depend on each individual's
unique facts and circumstances," the Associated Press reports.


TOSHIBA AMERICA: Recalls 3,400 Rear Televisions For Shock Hazard
----------------------------------------------------------------
Toshiba America Consumer Products, Inc. is cooperating with the
United States Consumer Product Safety Commission by recalling
3,400 Rear Projection Televisions.  If the capacitors short
circuit due to a very high electrical surge, such as from a
lightening strike, the metal parts on the television could
present a shock or electrocution hazard.  In addition, the metal
jacks on the back of the television or another metal box
attached to the television could present a shock or
electrocution hazard as a result of the capacitors' failure.  No
injuries have been reported.

This program includes a limited number of units of the following
Toshiba rear projection televisions: Model 50A62, Model 51H83,
and Model 57H83. These products were sold at Consumer electronic
stores, department stores, and mass merchandisers nationwide
from April 21, 2003 through May 8, 2003 for between $999 and
$2200.

For more details, contact the Company by Phone: (877) 290-6064,
24 hours a day, 7 days a week or visit the firm's Website:
http://www.tacp.toshiba.com/service/safety_notice.asp


WORLDCOM INC.: SEC Submits Revisions To Civil Penalty Settlement
----------------------------------------------------------------
The United States Securities and Exchange Commission filed
documents modifying the proposed settlement of its claim for a
civil penalty in its civil action against WorldCom Inc. in the
United States District Court in the Southern District of New
York.  

The filings supplement the relief provisions in the proposed
settlement previously filed in that action on May 19, 2003,
which required WorldCom to pay a civil penalty judgment in the
amount of $1,510,000,000.  That proposed settlement further
provided that, as a result of the Company's pending bankruptcy
case, the Commission's judgment would be satisfied by WorldCom's
payment, after review and approval of the terms of the
settlement by the Bankruptcy Court, of $500,000,000.  
     
Following the parties' agreement on the terms of the proposed
settlement, and after an initial hearing before the District
Court and in light of issues raised by the District Court Judge,
WorldCom and the SEC mutually agreed to supplement to the terms
of the proposed settlement.  

The modifications to the proposed settlement to which the
Official Committee of Unsecured Creditors of WorldCom has
consented, provide that in the event of confirmation of a plan
of reorganization of WorldCom by the Bankruptcy Court,
WorldCom's obligations under the Commission's judgment shall be
deemed to be satisfied by the company's payment of $500,000,000
in cash and by its transfer of common stock in the reorganized
company having a value of $250,000,000 to a court-appointed
distribution agent.  

The supplemental relief, if approved, would allow victims of the
fraud to share in the potential upside of owning WorldCom common
stock when it emerges from bankruptcy.  All other material terms
of the proposed settlement remain the same.  The proposed
settlement is subject to review and approval of the District
Court hearing the Commission's action against WorldCom and the
Bankruptcy Court handling WorldCom's bankruptcy case (which is
also in the Southern District of New York).
     
Under the terms of the proposed settlement, the funds paid and
the common stock transferred by WorldCom to satisfy the
Commission's judgment will be distributed to victims of the
company's fraud, pursuant to Section 308 (Fair Funds For
Investors) of the Sarbanes-Oxley Act of 2002.

The Commission has alleged that WorldCom misled investors by
overstating its income from at least as early as 1999 through
the first quarter of 2002, as a result of undisclosed and
improper accounting.  The Commission filed its case against
WorldCom on June 26, 2002, the day after WorldCom announced that
it intended to restate its financial results for five quarters-
all quarters in 2001 and the first quarter of 2002.   

The Commission also sought the appointment of a corporate
monitor for WorldCom, and on July 3, US District Judge Jed S.
Rakoff appointed former SEC Chairman Richard Breeden to that
position.

On November 26, 2002, the Commission obtained a judgment against
WorldCom through which the Commission obtained the full
injunctive relief it sought against WorldCom.  In addition, the
judgment ordered WorldCom to undertake extensive reviews of its
corporate governance and internal controls, as well as required
the WorldCom to establish a training and education program for
WorldCom officers and employees to minimize the possibility of
future violations of the federal securities laws.   The judgment
explicitly left open the determination of monetary penalties to
be imposed on WorldCom.  
     
Since the Commission filed its action against WorldCom, the
company has made a series of announcements expanding its
anticipated financial restatement due to the fraud, both in
dollar amount and in time.  In addition, the Commission has
brought civil actions against four former employees of WorldCom.   
The Commission filed civil actions against former WorldCom
Controller David F. Myers on September 26, 2002 (LR-17753);
former WorldCom Director of General Accounting Buford  "Buddy"
Yates, Jr., on October 7, 2002, (LR-17771); and Betty L. Vinson
and Troy M. Normand, former accountants in the WorldCom's
General Accounting Department, on October 10, 2002, (LR-17783).  
All of these actions are pending.


X-CEL FEEDS: Signs Consent Decree Over Food & Drug Act Violation
----------------------------------------------------------------
The Food and Drug Administration (FDA) filed a consent decree of
permanent injunction against X-Cel, Feeds Inc., and individual
officers based on violations of the Food, Drug and Cosmetic Act.  
In the consent decree, the Company and officers admitted
liability for introducing adulterated and misbranded animal
feeds into interstate commerce and agreed to implement measures
to correct the violations under FDA's supervision.

X-Cel, a feed manufacturer headquartered in Tacoma, Washington,
failed to comply with FDA regulations (the 1997 Animal Feed
Rule) designed to prevent the establishment and spread of Bovine
Spongiform Encephalopathy (BSE, also known as "Mad Cow Disease")
should it ever be found in the United States and FDA regulations
concerning the manufacture of medicated feeds.

"No case of BSE has ever been documented in the U.S., despite
aggressive surveillance," said FDA Commissioner Mark B.
McClellan, M.D., Ph.D.  "FDA's animal feed regulations provide a
firewall against BSE, and we are committed to strictly enforcing
the rules that protect Americans from this disease."

The Department of Justice, Civil Division, Office of Consumer
Litigation and the United States Attorney's Office of the
Western District of Washington filed the Consent Decree in the
United States District Court of the Western District in Tacoma,
Washington.  It permanently enjoins X-Cel from manufacturing
animal feeds in violation of the Food Drug and Cosmetic Act and
requires the firm, its officers, and employees to take specific
steps to avoid future violations including, implementing clean-
out procedures, obtaining protein supplier certifications and
implementing standard operating procedures for compliance until
it satisfies FDA that it has corrected its problems.

FDA's animal feed regulations protect the United States from the
potential threat of BSE by prohibiting the use of certain
proteins derived from mammalian tissue in the feed for cattle
and other ruminant animals.

X-Cel and its officers have signed and consented to the filing
and entry of the decree, which will take effect once it has been
signed by a judge and entered by the court.


                Meetings, Conferences & Seminars


* Scheduled Events for Class Action Professionals
-------------------------------------------------


July 16-17, 2003
MANAGING MOLD LIABILITIES
Bridgeport Continuing Education
San Francisco
Contact: 818-505-1490

July 31-August 1, 2003  
CLASS ACTION LITIGATION 2003: PROSECUTION AND DEFENSE STRATEGIES
Practising Law Institute
PLI New York Center
Contact: 800-260-4PLI; info@pli.edu.

August 1, 2003
CLASS ACTION LITIGATION 2003: PROSECUTION AND DEFENSE STRATEGIES
Practising Law Institute
PLI New York Center
Contact: 800-260-4PLI; info@pli.edu.

August 26-27, 2003
THE ANNUAL MANAGING MOLD LIABILITIES CONFERENCE
FROM CONSTRUCTION THROUGH TRIAL
Bridgeport Continuing Education
Contact: http://www.reconferences.com;818-505-1490

September 8-9, 2003
CORPORATE GOVERNANCE: LIABILITY OF CORPORATE
OFFICERS AND DIRECTORS
Mealey Publications
The Ritz-Carlton Hotel Amelia Island, FL
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

September 8-10, 2003
NATIONAL ASBESTOS LITIGATION CONFERENCE
Mealey Publications
The Ritz-Carlton Hotel Chicago
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

September 11-12, 2003
MASS TORT LITIGATION TOOLS FOR PARALEGALS
Mealey Publications
The Westin Hotel, Philadelphia
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

September 15-16, 2003  
SECURITIES LITIGATION & ENFORCEMENT 2003
Practising Law Institute
PLI New York Center
Contact: 800-260-4PLI; info@pli.edu.

September 18-19, 2003
REINSURANCE SUMMIT
Mealey Publications
The Westin Hotel, Chicago
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

September 19-21, 2003
THE 20TH TOBACCO PRODUCTS LIABILITY PROJECT CONFERENCE
Northeastern University School of Law
Contact: scuri@tplp.org

September 22-23, 2003
BAD FAITH CONFERENCE
Mealey Publications
The Westin Hotel, Philadelphia
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

September 26, 2003
MANAGING ENVIRONMENTAL RISKS
Bridgeport Continuing Education
Los Angeles
Contact: 818-505-1490

September 29-30, 2003
PRACTICAL SKILLS SERIES: MASS TORT LITIGATION
Mealey Publications
The Ritz-Carlton Hotel, Philadelphia
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

September 29-30, 2003
CONSUMER FINANCE CLASS ACTIONS
American Conference Institute
New York City
Contact: 1-888-224-2480; http://www.americanconference.com  

October 2-3, 2003
SECURITIES LITIGATION & ENFORCEMENT 2003
Practising Law Institute
PLI New York Center
Contact: 800-260-4PLI; info@pli.edu.

October 8-9, 2003
ASBESTOS LITIGATION
American Conference Institute
New York City
Contact: 1-888-224-2480; http://www.americanconference.com  

October 13-14, 2003
SILICA LITIGATION CONFERENCE
Mealey Publications
The Ritz-Carlton Hotel, Atlanta
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

October 15, 2003
LEXISNEXIS PRESENTS WALL STREET FORUM:
PHARMACEUTICAL & MEDICAL DEVICE INDUSTRY LITIGATION
Mealey Publications
The Ritz-Carlton New York, Battery Park
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

October 16-17, 2003
LEAD LITIGATION CONFERENCE
Mealey Publications
Westin Copley Plaza, Boston
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

October 24, 2003
7TH ANNUAL NATIONAL INSTITUTE ON CLASS ACTIONS
American Bar Association
San Francisco, CA
Contact: 800-285-2221; abacle@abanet.org

November 6-7, 2003
SECURITIES, DRUGS & ENVIRONMENTAL LITIGATION
MassTortsMadePerfect.Com
Ritz Carlton, New Orleans, Louisiana
Contact: 1-800-320-2227; register@masstortsmadeperfect.com

November 7, 2003
7TH ANNUAL NATIONAL INSTITUTE ON CLASS ACTIONS
American Bar Association
Washington, DC
Contact: 800-285-2221; abacle@abanet.org

November 10-11, 2003
FEN-PHEN LITIGATION CONFERENCE
Mealey Publications
The Four Seasons Hotel, Houston
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

November 13-14, 2003
MASS TORT LITIGATION TOOLS FOR PARALEGALS
Mealey Publications
The Westin Bonaventure Hotel, Los Angeles
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com  

November 13-14, 2003
ASBESTOS LITIGATION IN THE 21ST CENTURY
ALI-ABA
New Orleans
Contact: 215-243-1614; 800-CLE-NEWS x1614

November 17, 2003
WATER CONTAMINATION LITIGATION CONFERENCE
Mealey Publications
Pasadena
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

November 17-18, 2003
INSURANCE ALLOCATION CONFERENCE
Mealey Publications
The Ritz-Carlton Golf Resort, Naples, FL
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

November 18, 2003
MEDICAL MONITORING CONFERENCE
Mealey Publications
The Ritz-Carlton Huntington Hotel & Spa, Pasadena
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

December 8-9, 2003
ASBESTOS PREMISES LIABILITY CONFERENCE
Mealey Publications
The Fairmont Hotel, San Francisco
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

December 8-9, 2003
CALIFORNIA SECTION 17200 CONFERENCE
Mealey Publications
The Fairmont Hotel, San Francisco
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

December 11-12, 2003
CONSTRUCTION DEFECT AND MOLD LITIGATION CONFERENCE
Mealey Publications
The Ritz-Carlton, Lake Las Vegas, Las Vegas
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

December 12, 2003
MOLD LITIGATION 101 CONFERENCE
Mealey Publications
The Ritz-Carlton, Lake Las Vegas, Las Vegas
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

January 22-23, 2004
ENVIRONMENTAL AND TOXIC TORT MATTERS: ADVANCED CIVIL LITIGATION
ALI-ABA
Orlando (Walt Disney World)
Contact: 215-243-1614; 800-CLE-NEWS x1614

March 18-19, 2004
SECURITIES, DRUGS & ENVIRONMENTAL LITIGATION
MassTortsMadePerfect.Com
The Fairmont, San Francisco, California
Contact: 1-800-320-2227; register@masstortsmadeperfect.com
    
June 10 & 11, 2004
SECURITIES, DRUGS & ENVIRONMENTAL LITIGATION
MassTortsMadePerfect.Com
Atlantis, Paradise Island, Bahamas
Contact: 1-800-320-2227; register@masstortsmadeperfect.com

TBA
FAIR LABOR STANDARDS CONFERENCE
Mealey Publications
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com

TBA
AIRLINE BANKRUPTCY LITIGATION CONFERENCE
Mealey Publications
Contact: 1-800-MEALEYS; 610-768-7800;
mealeyseminars@lexisnexis.com




* Online Teleconferences
------------------------

July 18, 2003
CLASS ACTION OVERVIEW
American Bar Association
Contact: 800-285-2221; abacle@abanet.org

ADVERSARIAL PROCEEDINGS IN ASBESTOS BANKRUPTCIES
LawCommerce.Com/Mealey's
Online Streaming Video
Contact: customerservice@lawcommerce.com

ASBESTOS BANKRUPTCY - PANEL OF CREDITORS COMMITTEE MEMBERS
LawCommerce.Com/Mealey's
Online Streaming Video
Contact: customerservice@lawcommerce.com

EXPERT WITNESS ADMISSIBILITY IN MOLD CASES
LawCommerce.Com/Mealey's
Online Streaming Video
Contact: customerservice@lawcommerce.com

INTRODUCTION TO CLASS ACTIONS AND LARGE RECOVERIES
Big Class Action
Contact: seminars@bigclassaction.com

NON-TRADITIONAL DEFENDANTS IN ASBESTOS LITIGATION
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

PAXIL LITIGATION
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

RECENT DEVELOPMENTS INVOLVING BAYCOL
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

RECOVERIES
Big Class Action
Contact: seminars@bigclassaction.com

SELECTION OF MOLD LITIGATION EXPERTS: WHO YOU NEED ON YOUR TEAM
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

SHOULD I FILE A CLASS ACTION?
LawCommerce.Com / Law Education Institute
Contact: customerservice@lawcommerce.com

THE EFFECTS OF ASBESTOS ON THE PULMONARY SYSTEM
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

THE STATE OF ASBESTOS LITIGATION: JUDICIAL PANEL DISCUSSION
Online Streaming Video
LawCommerce.Com/Mealey's
Contact: customerservice@lawcommerce.com

TRYING AN ASBESTOS CASE
LawCommerce.Com
Contact: customerservice@lawcommerce.com

THE IMPACT OF LORILLAR ON STATE AND LOCAL REGULATION OF TOBACCO
SALES
AND ADVERSTISING
American Bar Association
Contact: 800-285-2221; abacle@abanet.org

________________________________________________________________
The Meetings, Conferences and Seminars column appears in the
Class Action Reporter each Wednesday.  Submissions via e-mail to
carconf@beard.com are encouraged.


                    New Securities Fraud Cases


CRYO-CELL INTERNATIONAL: Rabin Murray Lodges Stock Lawsuit in FL
----------------------------------------------------------------
Rabin Murray & Frank LLP initiated a securities class action in
the United States District Court for the Middle District of
Florida, on behalf of all persons or entities who purchased or
otherwise acquired Cryo-Cell International securities
(NasdaqSC:CCCEC) during the period March 16, 1999 to May 20,
2003, both dates inclusive.  The suit names as defendants the
Company and:

     (1) Mercedes Walton,

     (2) Gerald F. Maass,

     (3) Jill M. Taymans,

     (4) Edward Modzelewski,

     (5) Frederick C. S. Wilhelm,

     (6) Wanda D. Dearth,

     (7) Junior Winokur,

     (8) Daniel D. Richard,

     (9) Ronald Richard,

    (10) Charles D. Nyberg,

    (11) John V. Hargiss,

    (12) Weinick Sanders Leventhal & Co., LLP, and

    (13) Mirsky, Furst & Associates, P.A.

The complaint alleges that defendants violated section 10(b) of
the Securities Exchange Act of 1934 and Rule 10b-5 promulgated
thereunder by the Securities and Exchange Commission.  In
particular, the Complaint alleges that defendants failed to
disclose and/or misrepresented the following adverse facts,
among others:

     (i) that the Company had materially overstated its
         earnings, net income, and earnings per share;

    (ii) that the Company continually recognized revenue in
         violation of generally accepted accounting principles
         (GAAP) and the Company's own internal accounting
         principles with respect to related-party transactions,
         revenue sharing agreements and revenue recognition for
         the Sale Area Licenses;

   (iii) that the Company lacked adequate internal controls and
         was therefore unable to ascertain the true financial
         condition of the Company; and

    (iv) that as a result, the Company's financial results were
         materially overstated at all relevant times.

On April 15, 2003, the Company issued a press release wherein it
disclosed that it may be necessary to restate its financial
results for fiscal years 2001 and 2002 because of improper
recognition of revenue.  Shortly thereafter, on May 20, 2003,
the Company issued a press release announcing the resignation of
its auditor, Ernst & Young LLP and the Company's continued
assessment of certain revenue recognition accounting policies.  
On news of this, Cryo-Cell shares fell 14%.

For more details, contact Eric J. Belfi or Sharon Lee by Phone:
(800) 497-8076 or (212) 682-1818 by Fax: (212) 682-1892 or by E-
mail: email@rabinlaw.com


DAISYTEK INTERNATIONAL: Bernstein Liebhard Lodges TX Stock Suit
---------------------------------------------------------------
Bernstein Liebhard & Lifshitz LLP initiated a securities class
action on behalf of all persons who acquired securities of
Daisytek International Corporation (NasdaqNM:DZTK) between
November 9, 2001 and April 28, 2003, inclusive.  The case is
pending in the United States District Court for the Eastern
District of Texas, Sherman Division against the Company and:

     (1) James R. Powell,

     (2) Ralph Mitchell and

     (3) Peter Wharf

The complaint charges that Daisytek and certain of its officers
and directors violated Sections 10(b) and 20(a) of the
Securities Exchange Act of 1934, and Rule 10b-5 promulgated
thereunder, by issuing a series of material misrepresentations
to the market about the Company's business, operating
performance, and prospects during the Class Period, thereby
inflating the price of Daisytek securities.

Specifically, the Complaint alleges that the Company improperly
accounted for uncollectible customer accounts receivables and
vendor rebates receivables to inflate the Company's results.  As
a result of this misconduct, certain defendants were able to
sell their personal holdings in the Company's stock for over a
million dollars in proceeds.

The class period ends on April 28, 2003 when Daisytek issued a
press release announcing that the Company expected a significant
loss in its fourth quarter 2003.  The press release stated that
Daisytek would record significant write-downs of customer
receivables, vendor receivables, and inventory.  Additionally,
the Company stated that it would incur large restructuring
charges.  

When this news was revealed, the price of Daisytek stock dropped
more than 70% to close at $0.53 per share the following day, on
extraordinarily high trading volume.

For more details, contact Ms. Linda Flood, Director of
Shareholder Relations, by Mail: 10 East 40th Street, New York,
New York 10016 by Phone: (800) 217-1522 or 212-779-1414 or by E-
mail: DZTK@bernlieb.com.


SINGING MACHINE: Vianale & Vianale Lodges Securities Suit in FL
---------------------------------------------------------------
Vianale & Vianale LLP filed a securities class action lawsuit on
behalf of investors who purchased the securities of The Singing
Machine Company, Inc. (AMEX:SMD) during the class period
February 14, 2001 and June 27, 2003 in the United States
District Court for Southern District of Florida.

The lawsuit alleges that defendants artificially inflated the
price of The Singing Machine's securities during the class
period by issuing materially false and misleading financial
statements.  Specifically, the lawsuit alleges defendants
repeatedly issued financial statements that did not account for
the Company's probable liability for Hong Kong income taxes.  
Defendants, however, had no basis to claim they would receive
any tax exemption from Hong Kong authorities, and should have
appropriately reserved for the tax payments.

On June 27, 2003, the Company revealed that it would seek an
extension to file its Annual Report on Form 10-K for fiscal 2003
and that it would restate its fiscal 2002 and possibly 2001
financial statements.  The restatement was prompted by the
Company's admission of a need to increase an accrual for income
taxes that may be payable to Hong Kong authorities.  The stock
price dropped 33% on the news.  The Company's auditor is also
named as a defendant in the suit.

For more details, contact Kenneth J. Vianale or Julie Prag
Vianale by Mail: 5355 Town Center Road, Suite 801, Boca Raton,
Florida 33486 by Phone: 1-888-657-9960 or 561-391-4900 or by E-
mail: info@vianalelaw.com


                        *********

A list of Meetings, Conferences and Seminars appears in each
Wednesday's edition of the Class Action Reporter. Submissions
via e-mail to carconf@beard.com are encouraged.

Each Friday's edition of the CAR includes a section featuring
news on asbestos-related litigation and profiles of target
asbestos defendants that, according to independent researches,
collectively face billions of dollars in asbestos-related
liabilities.  The Asbestos Defendant Profiles is backed by an
online database created to respond to custom searches. Go to
http://litigationdatasource.com/asbestos_defendant_profiles.html

                        *********


S U B S C R I P T I O N   I N F O R M A T I O N

Class Action Reporter is a daily newsletter, co-published by
Bankruptcy Creditors' Service, Inc., Trenton, New Jersey, and
Beard Group, Inc., Washington, D.C.  Enid Sterling, Aurora
Fatima Antonio and Lyndsey Resnick, Editors.

Copyright 2003.  All rights reserved.  ISSN 1525-2272.

This material is copyrighted and any commercial use, resale or
publication in any form (including e-mail forwarding, electronic
re-mailing and photocopying) is strictly prohibited without
prior written permission of the publishers.

Information contained herein is obtained from sources believed
to be reliable, but is not guaranteed.

The CAR subscription rate is $575 for six months delivered via
e-mail.  Additional e-mail subscriptions for members of the same
firm for the term of the initial subscription or balance thereof
are $25 each.  For subscription information, contact Christopher
Beard at 240/629-3300.

                  * * *  End of Transmission  * * *